CTOs on the Move

Bright Dental USA

www.brightdentalusa.com

 
Bright Dental USA is a Glenview, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

OrthoSupply Management

OrthoSupply Management is a Marlborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

r4 Vascular

r4 Vascular, Inc. is a Maple Grove, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardinal Health Canada

Cardinal Health Canada is a Concord, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medafor

Medafor is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Musculoskeletal Clinical Regulatory Advisers

MCRA is the leading global full-service medical device, diagnostics, and biologics CRO and consulting advisory firm. MCRA delivers to its client`s industry experience, integrating its six business value creators: regulatory, clinical research, reimbursement, healthcare compliance, quality assurance, and distribution logistics to provide a dynamic, market-leading effort from innovation conception to commercialization. MCRA`s integrated application of these key value-creating initiatives provides unparalleled value for its clients. MCRA has offices in Washington, DC, Hartford, CT, New York, NY, and Tokyo, Japan and serves nearly 1,000 clients globally. Its core focus areas of therapeutic experience include orthopedics, spine, biologics, cardiovascular, diagnostic imaging, wound care, artificial intelligence, dental, anesthesia, general surgery, digital health, neurology, robotics, oncology, general and plastic surgery, urology, and in vitro diagnostic (IVD) devices and medical device cybersecurity. MCRA places particular emphasis on its expertise working with companies in all stages of development and throughout the technology life cycle by ushering technologies from the conceptual pre-clinical stage to market approval.